NCT01561781 Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib Status COMPLETED Phase PHASE1
NCT01551615 A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib Status COMPLETED Phase PHASE1
NCT01551069 Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion Status COMPLETED Phase PHASE3
NCT01548404 Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT01544140 Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib Status COMPLETED Phase PHASE1
NCT01541007 A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT01539655 Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib Status COMPLETED Phase PHASE1
NCT01537653 Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects Status COMPLETED Phase PHASE1
NCT01537640 Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01531205 Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA Status TERMINATED Phase PHASE2
NCT01529853 To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1/PHASE2
NCT01527929 Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment Status COMPLETED Phase PHASE1
NCT01524705 FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) Status COMPLETED Phase PHASE4
NCT01517412 Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin Status COMPLETED Phase PHASE3
NCT01515748 Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT01513031 Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation Status TERMINATED Phase PHASE4
NCT01511549 Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis Status COMPLETED Phase PHASE1
NCT01511536 Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01507831 Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) Status COMPLETED Phase PHASE3